Post has attachment
Increasing Public-Private Investments in the Field of Preimplantation Genetic Testing

For more Insights:- https://tinyurl.com/y7dpco2c

The report " #Preimplantation_Genetic_Testing Market by Type ( #Genetic_Diagnosis/ #Genetic_Screening), Technology ( #NGS, #PCR, #FISH, #CGH, #SNP), Products & Services, Application ( #Aneuploidy, #Translocations), End User ( #Fertility_Clinics, #Research) - Forecast to 2022", The global preimplantation genetic testing market is projected to reach USD 541.8 Million by 2022 from USD 336.4 Million in 2017, at a CAGR of 10.0%.

Factors such as the growing rate of infertility across the globe, increasing public-private investments in the field of preimplantation genetic testing, rising number of fertility clinics worldwide, technological advancements in the field of genetic analysis, and high risk of chromosomal abnormalities in the fetus with increasing maternal age are driving the growth of this market.

The aneuploidy segment is expected to grow at the fastest CAGR. Growth of this segment can be attributed to the increasing maternal age, rising incidence of aneuploidy disorders, and strategic initiatives by key players to provide technologically advanced PGS products for aneuploidy screening. Aneuploidy screening has been reported to increase the chance of successful embryo implantation, decreases miscarriage rate, and reduce the chance of having a child with a chromosome abnormality).

Post has attachment

Post has attachment

Post has attachment

Post has attachment

Post has attachment

Post has attachment

Post has attachment

Post has attachment

Post has attachment
Wait while more posts are being loaded